The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients.

Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART) including efavirenz is recommended as a 1(st)-line treatment choice in international HIV guidelines, and it is one of the most common components of initial therapy. Resistance to 1(st)-generatio...

Full description

Bibliographic Details
Main Authors: Sonya J Snedecor, Alexandra Khachatryan, Katherine Nedrow, Richard Chambers, Congyu Li, Seema Haider, Jennifer Stephens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3749990?pdf=render